• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于创伤性脑损伤中siRNA递送的聚乙二醇化多聚体RNA纳米颗粒

PEGylated Multimeric RNA Nanoparticles for siRNA Delivery in Traumatic Brain Injury.

作者信息

Han Sangwoo, Yoo Woojung, Carton Olivia, Joo Jinmyoung, Kwon Ester J

机构信息

Department of Bioengineering, University of California San Diego, La Jolla, CA, 92093, USA.

Department of Biomedical Engineering, Ulsan National Institute of Science and Technology (UNIST), Ulsan, 44919, Republic of Korea.

出版信息

Small. 2025 Mar;21(10):e2405806. doi: 10.1002/smll.202405806. Epub 2024 Nov 5.

DOI:10.1002/smll.202405806
PMID:39498752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11899522/
Abstract

Traumatic brain injury (TBI) impacts millions of people globally, however currently there are no approved therapeutics that address long-term brain health. In order to create a technology that is relevant for siRNA delivery in TBI after systemic administration, sub-100 nm nanoparticles with rolling circle transcription (RCT) are synthesized and isolated in order improve payload delivery into the injured brain. Unlike conventional RCT-based RNA particles, in this method, sub-100 nm RNA nanoparticles (RNPs) are isolated. To enhance RNP pharmacokinetics, RNPs are synthesized with modified bases in order to graft polyethylene glycol (PEG) to the RNPs. PEGylated RNPs (PEG-RNPs) do not significantly impact their knockdown activity in vitro and lead to longer blood half-life after systemic administration and greater accumulation into the injured brain in a mouse model of TBI. In order to demonstrate RNA interference (RNAi) activity of RNPs, knockdown of the inflammatory cytokine TNF-α in injured brain tissue after systemic administration of RNPs in a mouse model of TBI is demonstrated. In summary, small sub-100 nm multimeric RNA nanoparticles are synthesized and isolated that can be modified using accessible chemistry in order to create a technology suitable for systemic RNAi therapy for TBI.

摘要

创伤性脑损伤(TBI)在全球范围内影响着数百万人,然而目前尚无经批准的可解决长期脑健康问题的疗法。为了创建一种与全身给药后TBI中的小干扰RNA(siRNA)递送相关的技术,合成并分离出具有滚环转录(RCT)的亚100纳米纳米颗粒,以提高有效载荷向受伤大脑的递送。与基于传统RCT的RNA颗粒不同,在该方法中,分离出亚100纳米RNA纳米颗粒(RNP)。为了增强RNP的药代动力学,合成带有修饰碱基的RNP,以便将聚乙二醇(PEG)接枝到RNP上。聚乙二醇化RNP(PEG-RNP)在体外不会显著影响其敲低活性,并且在全身给药后导致更长的血液半衰期,并在TBI小鼠模型中更多地积聚到受伤大脑中。为了证明RNP的RNA干扰(RNAi)活性,在TBI小鼠模型中全身给药RNP后,证明了受伤脑组织中炎性细胞因子肿瘤坏死因子-α(TNF-α)的敲低。总之,合成并分离出亚100纳米的小多聚体RNA纳米颗粒,其可以使用易操作的化学方法进行修饰,以创建一种适用于TBI全身RNAi治疗的技术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f4d/11899522/83b3bf843f0b/SMLL-21-2405806-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f4d/11899522/4b6ec5047518/SMLL-21-2405806-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f4d/11899522/2d01d21a6005/SMLL-21-2405806-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f4d/11899522/97d174831a21/SMLL-21-2405806-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f4d/11899522/ddbcccb41bbe/SMLL-21-2405806-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f4d/11899522/7eeca268d488/SMLL-21-2405806-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f4d/11899522/dbdef4035485/SMLL-21-2405806-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f4d/11899522/83b3bf843f0b/SMLL-21-2405806-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f4d/11899522/4b6ec5047518/SMLL-21-2405806-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f4d/11899522/2d01d21a6005/SMLL-21-2405806-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f4d/11899522/97d174831a21/SMLL-21-2405806-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f4d/11899522/ddbcccb41bbe/SMLL-21-2405806-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f4d/11899522/7eeca268d488/SMLL-21-2405806-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f4d/11899522/dbdef4035485/SMLL-21-2405806-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f4d/11899522/83b3bf843f0b/SMLL-21-2405806-g007.jpg

相似文献

1
PEGylated Multimeric RNA Nanoparticles for siRNA Delivery in Traumatic Brain Injury.用于创伤性脑损伤中siRNA递送的聚乙二醇化多聚体RNA纳米颗粒
Small. 2025 Mar;21(10):e2405806. doi: 10.1002/smll.202405806. Epub 2024 Nov 5.
2
Analysis of PEG-lipid anchor length on lipid nanoparticle pharmacokinetics and activity in a mouse model of traumatic brain injury.聚乙二醇化脂质锚长度对创伤性脑损伤小鼠模型中脂质纳米颗粒药代动力学和活性的分析。
Biomater Sci. 2023 Jun 13;11(12):4238-4253. doi: 10.1039/d2bm01846b.
3
PEGylated cyclodextrins as novel siRNA nanosystems: correlations between polyethylene glycol length and nanoparticle stability.聚乙二醇化环糊精作为新型小干扰RNA纳米系统:聚乙二醇长度与纳米颗粒稳定性之间的相关性
Int J Pharm. 2014 Oct 1;473(1-2):105-12. doi: 10.1016/j.ijpharm.2014.06.054. Epub 2014 Jun 30.
4
BBB pathophysiology-independent delivery of siRNA in traumatic brain injury.BBB 病理生理学无关的 siRNA 递送至创伤性脑损伤。
Sci Adv. 2021 Jan 1;7(1). doi: 10.1126/sciadv.abd6889. Print 2021 Jan.
5
Comparison of Modular PEG Incorporation Strategies for Stabilization of Peptide-siRNA Nanocomplexes.用于稳定肽-siRNA纳米复合物的模块化聚乙二醇掺入策略的比较
Bioconjug Chem. 2016 Oct 19;27(10):2323-2331. doi: 10.1021/acs.bioconjchem.6b00304. Epub 2016 Sep 16.
6
Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles.通过静脉注射触发聚乙二醇化小干扰RNA纳米颗粒在体内控制乙肝病毒复制。
Mol Pharm. 2009 May-Jun;6(3):706-17. doi: 10.1021/mp800157x.
7
Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.用于癌症治疗中 siRNA 递送的基于脂质的纳米颗粒:范例与挑战。
Acc Chem Res. 2012 Jul 17;45(7):1163-71. doi: 10.1021/ar300048p. Epub 2012 May 8.
8
Rolling circle transcription-based polymeric siRNA nanoparticles for tumor-targeted delivery.基于滚环转录的聚合物 siRNA 纳米颗粒用于肿瘤靶向递药。
J Control Release. 2017 Oct 10;263:29-38. doi: 10.1016/j.jconrel.2017.03.390. Epub 2017 Mar 31.
9
Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.离子交联叶酸-聚(乙二醇)-壳寡糖乳酸纳米粒介导的高效siRNA递送及肿瘤蓄积:用于潜在的靶向卵巢癌基因治疗
Eur J Pharm Sci. 2014 Feb 14;52:48-61. doi: 10.1016/j.ejps.2013.10.011. Epub 2013 Oct 29.
10
Pharmacokinetic Analysis of Peptide-Modified Nanoparticles with Engineered Physicochemical Properties in a Mouse Model of Traumatic Brain Injury.载药纳米粒的药代动力学分析及其在创伤性脑损伤小鼠模型中的工程物理化学特性。
AAPS J. 2021 Aug 16;23(5):100. doi: 10.1208/s12248-021-00626-5.

引用本文的文献

1
Traumatic Brain Injury: Novel Experimental Approaches and Treatment Possibilities.创伤性脑损伤:新的实验方法与治疗可能性
Life (Basel). 2025 May 30;15(6):884. doi: 10.3390/life15060884.

本文引用的文献

1
Multifunctional rolling circle transcription-based nanomaterials for advanced drug delivery.基于多功能滚环转录的纳米材料用于先进药物输送。
Biomaterials. 2023 Oct;301:122241. doi: 10.1016/j.biomaterials.2023.122241. Epub 2023 Jul 8.
2
Analysis of PEG-lipid anchor length on lipid nanoparticle pharmacokinetics and activity in a mouse model of traumatic brain injury.聚乙二醇化脂质锚长度对创伤性脑损伤小鼠模型中脂质纳米颗粒药代动力学和活性的分析。
Biomater Sci. 2023 Jun 13;11(12):4238-4253. doi: 10.1039/d2bm01846b.
3
Stealth nanoparticles in oncology: Facing the PEG dilemma.
肿瘤学中的隐形纳米颗粒:面临 PEG 困境。
J Control Release. 2022 Nov;351:22-36. doi: 10.1016/j.jconrel.2022.09.002. Epub 2022 Sep 19.
4
Multimeric RNAs for efficient RNA-based therapeutics and vaccines.用于高效基于 RNA 的治疗和疫苗的多聚 RNA。
J Control Release. 2022 May;345:770-785. doi: 10.1016/j.jconrel.2022.03.052. Epub 2022 Mar 31.
5
Drug Delivery Challenges in Brain Disorders across the Blood-Brain Barrier: Novel Methods and Future Considerations for Improved Therapy.跨越血脑屏障的脑部疾病中的药物递送挑战:改善治疗的新方法及未来考量
Biomedicines. 2021 Dec 4;9(12):1834. doi: 10.3390/biomedicines9121834.
6
Pharmacokinetic Analysis of Peptide-Modified Nanoparticles with Engineered Physicochemical Properties in a Mouse Model of Traumatic Brain Injury.载药纳米粒的药代动力学分析及其在创伤性脑损伤小鼠模型中的工程物理化学特性。
AAPS J. 2021 Aug 16;23(5):100. doi: 10.1208/s12248-021-00626-5.
7
BBB pathophysiology-independent delivery of siRNA in traumatic brain injury.BBB 病理生理学无关的 siRNA 递送至创伤性脑损伤。
Sci Adv. 2021 Jan 1;7(1). doi: 10.1126/sciadv.abd6889. Print 2021 Jan.
8
Double Controlled Release of Therapeutic RNA Modules through Injectable DNA-RNA Hybrid Hydrogel.通过可注射 DNA-RNA 杂化水凝胶实现治疗性 RNA 模块的双重控制释放。
ACS Appl Mater Interfaces. 2020 Dec 16;12(50):55554-55563. doi: 10.1021/acsami.0c12506. Epub 2020 Dec 1.
9
Drug development in targeting ion channels for brain edema.靶向离子通道治疗脑水肿的药物研发。
Acta Pharmacol Sin. 2020 Oct;41(10):1272-1288. doi: 10.1038/s41401-020-00503-5. Epub 2020 Aug 27.
10
Nanomedicine for Acute Brain Injuries: Insight from Decades of Cancer Nanomedicine.急脑损伤的纳米医学:来自癌症纳米医学几十年的洞察。
Mol Pharm. 2021 Feb 1;18(2):522-538. doi: 10.1021/acs.molpharmaceut.0c00287. Epub 2020 Jun 25.